Page 58 - Read Online
P. 58

Latorre-Rodríguez et al. Mini-invasive Surg 2023;7:6  https://dx.doi.org/10.20517/2574-1225.2022.104  Page 7 of 10



































                Figure 3. Illustration of the (A) intraluminal and (B) intracavitary placement of the E-vac device in the endoscopic management of
                esophageal anastomotic leaks. (Used with permission from Norton Thoracic Institute, St. Joseph’s Hospital, and Medical Center,
                Phoenix, Arizona).

               same study, SEMS placement had a 77% (23/30) success rate. Additional recent alternatives for the
               minimally invasive management of esophageal ALs, including the use of endoscopic clips, endoscopic
               overstitch systems like OverStitch (Apollo Endosurgery, Inc.), and continuous suture systems, have had
               limited success .
                            [4]

               Interventional radiology or image-guided procedures have boomed in recent decades due to the increasing
               availability of expertise and decreasing complications and costs. In the field of thoracic surgery, multiple
               successful attempts at percutaneous CT-guided drainage of mediastinal or peri-esophageal abscesses have
               been reported and appear to be associated with higher success rates than SEMS; however, interventional
               radiology management for esophageal ALs is still unstandardized and a very uncommon (stand-alone)
                        [41]
               procedure . Furthermore, clinical trials are required to elucidate the full risks and benefits of this
               approach .
                       [41]
               The management of ALs of the foregut is focused on prevention, the use of minimally invasive endoscopic
               technologies, and personalized therapies. One interesting preclinical study that decreased the rate of ALs
               was performed in an animal model and used gene therapy with recombinant human vascular endothelial
               growth factor by direct injection of a non-viral plasmid-based delivery system . Furthermore, early clinical
                                                                                 [42]
               and preclinical studies have shown promising results from the peri-anastomotic administration of biologics,
               such as porcine fibrin sealant , as well as cell therapy, such as autografting stromal cells in fibrin scaffold
                                                                                                        [44]
                                        [43]
               and mesenchymal stem cells with or without platelet-rich plasma [45,46] .
               CONCLUSIONS
               ALs after surgical intervention in the gastrointestinal tract, including the esophagus, are an infrequent
   53   54   55   56   57   58   59   60   61   62   63